Teva shares surge 5% on news of patent settlement with Neos over ADHD drug
December 26, 2018 at 13:52 PM EST
Shares of generic drug maker Teva Pharmaceuticals Industries Ltd. rose about 5% Wednesday on news of a settlement and licensing agreement with Neos Therapeutics Inc. to resolve a patent dispute about a treatment for attention deficit disorders, or ADHD.